219 Summary and general discussion 9 49. Brown, S. M. et al. Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study. Critical Care Medicine 45, 1317–1324 (2017). 50. Thwaites, G. E. et al. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet 391, 668–678 (2018). 51. Dolby, H. W., Clifford, S. A., Laurenson, I. F., Fowler, V. G. & Russell, C. D. Heterogeneity in Staphylococcus aureus Bacteraemia Clinical Trials Complicates Interpretation of Findings. The Journal of Infectious Diseases 226, 723–728 (2022). 52. Grillo, S. et al. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial. Nature Medicine 29, 2518–2525 (2023). 53. Bakk, Z. & Kuha, J. Two-Step Estimation of Models Between Latent Classes and External Variables. Psychometrika 83, 871–892 (2018). 54. Calfee, C. S. et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. The Lancet. Respiratory Medicine 2, 611–620 (2014). 55. Calfee, C. S. et al. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. The Lancet Respiratory Medicine 6, 691–698 (2018). 56. Ni, Y.-N., Chen, G., Sun, J., Liang, B.-M. & Liang, Z.-A. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Critical Care (London, England) 23, 99 (2019). 57. Paules, C. I. & Fauci, A. S. Influenza Vaccines: Good, but We Can Do Better. The Journal of Infectious Diseases 219, S1–S4 (2019). 58. Lansbury, L., Lim, B., Baskaran, V. & Lim, W. S. Co-infections in people with COVID-19: a systematic review and meta-analysis. The Journal of Infection 81, 266–275 (2020). 59. Knight, S. R. et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ m3339 (2020) doi:10.1136/bmj.m3339.
RkJQdWJsaXNoZXIy MTk4NDMw